Skip to main content
. 2020 Jul;13(7):1549–1560. doi: 10.1016/j.jcmg.2019.05.023

Central Illustration.

Central Illustration

Using Coronary 18F-Fluoride to Identify Patients Who May Benefit From Intensified Dual Antiplatelet Therapy

Coronary 18F-fluoride positron emission tomography was used to identify high-risk coronary plaque in patients with stable multivessel coronary artery disease. Randomization to intensified dual antiplatelet therapy with ticagrelor did not reduce plasma high-sensitivity cardiac troponin I concentrations at 30 days in patients with high-risk plaque.